Second-trimester double or triple screening for Down syndrome: A comparison of Chinese and Caucasian populations

被引:29
|
作者
Wang, Yuan-Yuan
Luo, Jun
Zhu, Ming-Wei
Liu, Lan-Nv
Ma, Xu
机构
[1] Natl Res Inst Family Planning, WHO Collaborating Ctr Res Human Reprod, Beijing 100081, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll, Beijing 100037, Peoples R China
[3] Int Peace Hosp Protect Mother & Childs Hlth, China Welf Inst, Shanghai, Peoples R China
[4] Fudan Univ, Obstet & Gynecol Hosp, Med Ctr, Shanghai 200433, Peoples R China
[5] Maternal & Fetal Hlth Hosp, Shanghai, Peoples R China
关键词
Down syndrome; prenatal screening; alpha fetoprotein; human chorionic gonadotrophin; unconjugated estriol;
D O I
10.1016/j.ijgo.2006.04.030
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To compare the performance of double screening (measuring maternal serum levels of a-fetoprotein [AFP] and total beta-human chorionic gonadotrophin [hCG] as markers for Down syndrome) with that of triple screening (also measuring levels of unconjugated estriol [uE3]) in the second trimester of pregnancy, and to compare ethnic variance between Chinese and Caucasian populations. Methods: The study investigated 15096 normal singleton pregnancies and 24 pregnancies affected with Down syndrome. Frequency distributions of AFP, hCG, and uE3 levels were analyzed. Likelihood ratios (LRs) were calculated using the multiple of median value (MoM) of AFP, hCG, and uE3 as variables. After multiplying maternal age risk by the LR values for the markers used in double and triple screening, the specific risks obtained with double and triple screening were estimated. The detection rate (DR) and false-positive rate (FPR) were calculated at different cut-off points. The serum markers' levels were also compared with those of Caucasian women. Results: The median MoM value of hCG was higher in women with affected pregnancies (1.40) than those with unaffected pregnancies (1.00). However, the median MoMs of AFP and uE3 (0.79 and 0.68) were lower in affected than in unaffected pregnancies. At a FPR of 5%, the detection rates reached with double and triple screening were 50% and 66.7%, respectively. Ratios of the 3 serum markers' medians to those in a study with Caucasian women were 1.06 (range = 1.04-1.09) for AFP, 1.14 (range = 1.10-1.17) for hCG, and 1.28 (range = 1.23-1.41) for uE3 for the relevant gestational weeks. Conclusion: Triple screening performed better than double screening in the second trimester. Ethnic variance should be taken into account in Down syndrome screening. (c) 2006 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:67 / 72
页数:6
相关论文
共 50 条
  • [1] The analysis of second-trimester triple screening for Down syndrome in Chinese normal singleton pregnancies
    Wan, Xiaohua
    Wen, Jiangping
    Song, Xin
    Guo, Yongjun
    Liu, Xiangyi
    Yang, Benshan
    Lu, Xinxin
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2012, 72 (08) : 642 - 647
  • [2] Strict glycemic control in diabetic pregnancy - implications for second-trimester screening for Down syndrome
    Peled, Y
    Gilboa, Y
    Perri, T
    Shohat, M
    Chen, R
    Bar, J
    Hod, M
    Pardo, J
    PRENATAL DIAGNOSIS, 2003, 23 (11) : 888 - 890
  • [3] Second-trimester Triple Serum Tests in Women Screening for Down's Syndrome: A Meta Analysis
    Li, Kai
    Ma, Lei
    Xiang, Yan
    Han, Xiaodong
    Li, Long
    Zhu, Baosheng
    PROCEEDINGS OF 2016 IEEE INTERNATIONAL CONFERENCE ON BIG DATA ANALYSIS (ICBDA), 2016, : 315 - 318
  • [4] Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies
    Rice, JD
    McIntosh, SF
    Halstead, AC
    PRENATAL DIAGNOSIS, 2005, 25 (03) : 234 - 238
  • [5] Contingent triple-screening for Down syndrome in the second trimester: a feasibility study in Mainland Chinese population
    Xie, Zhenwei
    Lu, Shiming
    Li, Hui
    PRENATAL DIAGNOSIS, 2010, 30 (01) : 74 - 76
  • [6] Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity
    Muller, FO
    Dreux, S
    Dupoizat, H
    Uzan, S
    Dubin, MF
    Oury, JF
    Dingeon, B
    Dommergues, M
    PRENATAL DIAGNOSIS, 2003, 23 (04) : 331 - 335
  • [7] Agreement between predicted risk and prevalence of Down syndrome in second-trimester triple-marker screening in Japan
    Onda, T
    Tanaka, T
    Takeda, O
    Kitagawa, M
    Kuwabara, Y
    Yamamoto, H
    Iinuma, K
    Shimomura, K
    PRENATAL DIAGNOSIS, 1998, 18 (09) : 956 - 958
  • [8] Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance
    Rudnicka, AR
    Wald, NJ
    Huttly, W
    Hackshaw, AK
    PRENATAL DIAGNOSIS, 2002, 22 (10) : 893 - 897
  • [9] Comparison of the efficiency of second-trimester nasal bone hypoplasia and increased nuchal fold in Down syndrome screening
    Odibo, Anthony O.
    Sehdev, Harish M.
    Gerkowicz, Sabrina
    Stamilio, David M.
    Macones, George A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 199 (03) : 281.e1 - 281.e5
  • [10] ADAM 12 as a second-trimester maternal serum marker in screening for Down syndrome
    Christiansen, Michael
    Spencer, Kevin
    Laigaard, Jennie
    Cowans, Nicholas J.
    Larsen, Severin Olesen
    Wewer, Ulla M.
    PRENATAL DIAGNOSIS, 2007, 27 (07) : 611 - 615